Advanced Heart Failure and Transplant   

If so, what diastolic parameters do you look at? 

The basis of the question is that HFrEF trials enroll patients who have Class II-IV symptoms. If their LV systolic function recovers and they become a...

Would a decrease in eGFR by more than 30% prompt you to consider decreasing or discontinuing these medications?

Are there specific scenarios in which you employ BPAP with a back up rate?

Soloman, et al., PMID 39225278

Is your pattern for drug monitoring different if digoxin is being given for afib vs HFrEF? 

PARAGON HF trial, PMID: 31475794

Besides HR variability how can we explain resolution of the intermittent LBBB with HF GDMT (especially with ARNI use)? 

And who would you not recommend to undergo surgeries?

Do you have a specific protocol you follow during the stress echo, and if so, what echo parameters are you using to evaluate for exercised-induced hea...

How do you determine duration of therapy for Tafamidis, or is it continued indefinitely for the patient? 

In which clinical scenario(s) would you consider checking HVPG?

If PPCM is suspected, what are your targeted hemodynamic goals during the delivery phase? 

The EVEREST Outcome trial (Konstam et al., PMID 17384437)

If so, how frequently should we measure iron saturation/ferritin levels post-iron infusion?